20
Aurobindo Pharma Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Valsartan, Process II, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2011-174 - Rev 01
This Chemical Type CEP, issued on October 08, 2019, remains in force until January 31, 2022, ensuring its reliability within the pharmaceutical industry.
Substance Number 2423 associated with this CEP further emphasizes